Detailed Notes on Herbal supplements
Drugs where by compact distinctions in dose or blood concentration can lead to serious therapeutic failures and/or adverse, lifestyle-threatening reactions Have a very slim therapeutic index, in accordance with the FDA.A. No. Below part 301(ll) with the FD&C Act [21 U.S.C. § 331(ll)], it is prohibited to introduce or provide for introduction into